Dr. Uday R. Shankar

Hospital Medicine
Carle Health Care Incorporated
611 W Park St, 
Urbana, IL 
Carle Health Care Incorporated
611 W Park St, 
Urbana, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Uday Shankar is a Hospital Medicine provider in Urbana, Illinois. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Gallbladder Disease, Colonoscopy, and Endoscopy.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hospital Medicine
Licenses
Internal Medicine in MI
Hospital Affiliations
Carle Hoopeston Regional Health Center
Carle Foundation Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO

Locations

CARLE HEALTH CARE INCORPORATED
611 W Park St, Urbana, IL 61801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

12 Total Publications

Through-the-Scope Suturing for Late-Onset Fistula Closure in the Setting of Bariatric Surgery.
Through-the-Scope Suturing for Late-Onset Fistula Closure in the Setting of Bariatric Surgery.
Journal: The American surgeon
Published: November 15, 2023
Similar Doctors
Expertise in
6
conditions
Dr. Ioannis Karkatzounis
Hospital Medicine | Geriatrics | Sleep Medicine
Expertise in
6
conditions
Dr. Ioannis Karkatzounis
Hospital Medicine | Geriatrics | Sleep Medicine

Osf Multi-Specialty Group

1400 W Park St, 
Urbana, IL 
 (0.6 miles away)
217-337-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ioannis Karkatzounis is a Hospital Medicine specialist and a Geriatrics provider in Urbana, Illinois. Dr. Karkatzounis is highly rated in 6 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Sepsis, Necrosis, Bladder Reconstruction, and Hip Replacement. Dr. Karkatzounis is currently accepting new patients.

Expertise in
26
conditions
Dr. Danxuan Long
Pulmonary Medicine | Hospital Medicine
Expertise in
26
conditions
Dr. Danxuan Long
Pulmonary Medicine | Hospital Medicine

Hshs Medical Group Inc

1770 E Lake Shore Dr, Suite 300, 
Decatur, IL 
 (43.0 miles away)
217-422-0458
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Danxuan Long is a Pulmonary Medicine specialist and a Hospital Medicine provider in Decatur, Illinois. Dr. Long is highly rated in 26 conditions, according to our data. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Chronic Cough, and Atypical Pneumonia. Dr. Long is currently accepting new patients.

Expertise in
2
conditions
Dr. Sreenu P. Chakumgal
Hospital Medicine
Expertise in
2
conditions
Dr. Sreenu P. Chakumgal
Hospital Medicine

Carle Health Care Incorporated

611 W Park St, 
Urbana, IL 
 (0.1 miles away)
888-712-2753
Experience:
16+ years
Languages Spoken:
English
See accepted insurances

Sreenu Chakumgal is a Hospital Medicine provider in Urbana, Illinois. Dr. Chakumgal has been practicing medicine for over 16 years is highly rated in 2 conditions, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, End-Stage Renal Disease (ESRD), Endoscopy, and Ureteroscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shankar's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile